Amendment No. 1 to Schedule 13D for Rani Therapeutics Holdings, Inc.

This Amendment No. 1 to Schedule 13D, filed by Mir Imran and InCube Labs, L.L.C., updates the ownership details of Class A Common Stock of Rani Therapeutics Holdings, Inc. The amendment includes information on a private placement where Mir Imran purchased 2,083,334 shares of Class A Common Stock and 2,083,334 warrants at a combined price of $0.605 per share. The total purchase price was $1,260,417.07, funded by personal funds. The amendment also details changes to the Issuer's Amended and Restated Certificate of Incorporation, including reducing the voting power of Class B Common Stock from ten to one vote, eliminating the ability of stockholders to act by written consent, and adding stockholder protective provisions. Additionally, the Issuer agreed to file registration statements for the resale of shares issued in the private placement.